1
|
Sharma V, Madia VN, Tudino V, Nguyen JV, Debnath A, Messore A, Ialongo D, Patacchini E, Palenca I, Basili Franzin S, Seguella L, Esposito G, Petrucci R, Di Matteo P, Bortolami M, Saccoliti F, Di Santo R, Scipione L, Costi R, Podust LM. Miconazole-like Scaffold is a Promising Lead for Naegleria fowleri-Specific CYP51 Inhibitors. J Med Chem 2023; 66:17059-17073. [PMID: 38085955 PMCID: PMC10758121 DOI: 10.1021/acs.jmedchem.3c01898] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/10/2023] [Revised: 11/17/2023] [Accepted: 11/22/2023] [Indexed: 12/29/2023]
Abstract
Developing drugs for brain infection by Naegleria fowleri is an unmet medical need. We used a combination of cheminformatics, target-, and phenotypic-based drug discovery methods to identify inhibitors that target an essential N. fowleri enzyme, sterol 14-demethylase (NfCYP51). A total of 124 compounds preselected in silico were tested against N. fowleri. Nine primary hits with EC50 ≤ 10 μM were phenotypically identified. Cocrystallization with NfCYP51 focused attention on one primary hit, miconazole-like compound 2a. The S-enantiomer of 2a produced a 1.74 Å cocrystal structure. A set of analogues was then synthesized and evaluated to confirm the superiority of the S-configuration over the R-configuration and the advantage of an ether linkage over an ester linkage. The two compounds, S-8b and S-9b, had an improved EC50 and KD compared to 2a. Importantly, both were readily taken up into the brain. The brain-to-plasma distribution coefficient of S-9b was 1.02 ± 0.12, suggesting further evaluation as a lead for primary amoebic meningoencephalitis.
Collapse
Affiliation(s)
- Vandna Sharma
- Skaggs
School of Pharmacy and Pharmaceutical Sciences, Center for Discovery
and Innovation in Parasitic Diseases, University
of California San Diego, La Jolla, California 92093, United States
| | - Valentina Noemi Madia
- Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Valeria Tudino
- Dipartimento
di Biotecnologie, Università degli
Studi di Siena, Chimica e Farmacia via Aldo Moro 2, Siena 53100, Italy
| | - Jennifer V. Nguyen
- Skaggs
School of Pharmacy and Pharmaceutical Sciences, Center for Discovery
and Innovation in Parasitic Diseases, University
of California San Diego, La Jolla, California 92093, United States
| | - Anjan Debnath
- Skaggs
School of Pharmacy and Pharmaceutical Sciences, Center for Discovery
and Innovation in Parasitic Diseases, University
of California San Diego, La Jolla, California 92093, United States
| | - Antonella Messore
- Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Davide Ialongo
- Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Elisa Patacchini
- Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Irene Palenca
- Department
of Physiology and Pharmacology “V. Erspamer”, “Sapienza″ Università di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Silvia Basili Franzin
- Department
of Physiology and Pharmacology “V. Erspamer”, “Sapienza″ Università di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Luisa Seguella
- Department
of Physiology and Pharmacology “V. Erspamer”, “Sapienza″ Università di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Giuseppe Esposito
- Department
of Physiology and Pharmacology “V. Erspamer”, “Sapienza″ Università di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Rita Petrucci
- Dipartimento
di Scienze di Base e Applicate per l’Ingegneria, “Sapienza” Università di Roma, Via Castro Laurenziano 7, Rome 00161, Italy
| | - Paola Di Matteo
- Dipartimento
di Scienze di Base e Applicate per l’Ingegneria, “Sapienza” Università di Roma, Via Castro Laurenziano 7, Rome 00161, Italy
| | - Martina Bortolami
- Dipartimento
di Scienze di Base e Applicate per l’Ingegneria, “Sapienza” Università di Roma, Via Castro Laurenziano 7, Rome 00161, Italy
| | - Francesco Saccoliti
- D3 PharmaChemistry, Italian
Institute of Technology, Via Morego 30, Genova 16163, Italy
| | - Roberto Di Santo
- Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Luigi Scipione
- Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Roberta Costi
- Dipartimento
di Chimica e Tecnologie del Farmaco, Istituto Pasteur-Fondazione Cenci
Bolognetti, “Sapienza” Università
di Roma, p.le Aldo Moro 5, Rome I-00185, Italy
| | - Larissa M. Podust
- Skaggs
School of Pharmacy and Pharmaceutical Sciences, Center for Discovery
and Innovation in Parasitic Diseases, University
of California San Diego, La Jolla, California 92093, United States
| |
Collapse
|
2
|
Huang J, Song S, Zhao S, Sun X, Wang Z, Huang X, Xiao Q, Deng Y. Anti-virulence activity of novel (1-heteroaryloxy-2-hydroxypropyl)- phenylpiperazine derivatives against both wild-type and clinical drug-resistant Candida albicans strains. Microb Biotechnol 2022; 16:116-127. [PMID: 36404587 PMCID: PMC9803326 DOI: 10.1111/1751-7915.14169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2022] [Revised: 09/15/2022] [Accepted: 10/17/2022] [Indexed: 11/22/2022] Open
Abstract
Candida albicans is an important human fungal pathogen. Our previous study disclosed that aryloxy-phenylpiperazine skeleton was a promising molecule to suppress C. albicans virulence by inhibiting hypha formation and biofilm formation. In order to deeply understand the efficacy and mechanism of action of phenylpiperazine compounds, and obtain new derivatives with excellent activity against C. albicans, hence, we synthesized three series of (1-heteroaryloxy-2-hydroxypropyl)-phenylpiperazines and evaluated their inhibitory activity against C. albicans both in vitro and in vivo in this study. Compared with previously reported aryloxy-phenylpiperazines, part of these heteroaryloxy derivatives improved their activities by strongly suppressing hypha formation and biofilm formation in C. albicans SC5314. Especially, (9H-carbazol-4-yl)oxy derivatives 25, 26, 27 and 28 exhibited strong activity in reducing C. albicans virulence in both human cell lines in vitro and mouse infection models in vivo. The compound 27 attenuated the virulence of various clinical C. albicans strains, including clinical drug-resistant C. albicans strains. Moreover, additive effects of the compound 27 with antifungal drugs against drug-resistant C. albicans strains were also discussed. Furthermore, the compound 27 significantly improved the composition and richness of the faecal microbiota in mice infected by C. albicans. These findings indicate that these piperazine compounds have great potential to be developed as new therapeutic drugs against C. albicans infection.
Collapse
Affiliation(s)
- Junjun Huang
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated HospitalGuangzhou Medical UniversityGuangzhouChina
| | - Shihao Song
- School of Pharmaceutical Sciences (Shenzhen)Shenzhen Campus of Sun Yat‐sen University, Sun Yat‐sen UniversityShenzhenChina,School of Pharmaceutical SciencesHainan UniversityHaikouChina
| | - Shuo Zhao
- Integrative Microbiology Research Center, College of Plant ProtectionSouth China Agricultural UniversityGuangzhouChina,School of Basic MedicineZunyi Medical UniversityZunyiChina
| | - Xiuyun Sun
- School of Pharmaceutical Sciences (Shenzhen)Shenzhen Campus of Sun Yat‐sen University, Sun Yat‐sen UniversityShenzhenChina,School of Pharmaceutical SciencesHainan UniversityHaikouChina
| | - Zijie Wang
- School of Pharmaceutical Sciences (Shenzhen)Shenzhen Campus of Sun Yat‐sen University, Sun Yat‐sen UniversityShenzhenChina,Hunan Children's HospitalChangshaChina
| | - Xiaorong Huang
- College of Veterinary MedicineSouth China Agricultural UniversityGuangzhouChina
| | - Qing Xiao
- Guangzhou Municipal and Guangdong Provincial Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences and the Fifth Affiliated HospitalGuangzhou Medical UniversityGuangzhouChina
| | - Yinyue Deng
- School of Pharmaceutical Sciences (Shenzhen)Shenzhen Campus of Sun Yat‐sen University, Sun Yat‐sen UniversityShenzhenChina
| |
Collapse
|
3
|
Pricopie AI, Ionuț I, Marc G, Arseniu AM, Vlase L, Grozav A, Găină LI, Vodnar DC, Pîrnău A, Tiperciuc B, Oniga O. Design and Synthesis of Novel 1,3-Thiazole and 2-Hydrazinyl-1,3-Thiazole Derivatives as Anti- Candida Agents: In Vitro Antifungal Screening, Molecular Docking Study, and Spectroscopic Investigation of their Binding Interaction with Bovine Serum Albumin. Molecules 2019; 24:E3435. [PMID: 31546673 PMCID: PMC6804233 DOI: 10.3390/molecules24193435] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/08/2019] [Revised: 08/18/2019] [Accepted: 09/20/2019] [Indexed: 02/03/2023] Open
Abstract
In the context of there being a limited number of clinically approved drugs for the treatment of Candida sp.-based infections, along with the rapid development of resistance to the existing antifungals, two novel series of 4-phenyl-1,3-thiazole and 2-hydrazinyl-4-phenyl-1,3-thiazole derivatives were synthesized and tested in vitro for their anti-Candida potential. Two compounds (7a and 7e) showed promising inhibitory activity against the pathogenic C. albicans strain, exhibiting substantially lower MIC values (7.81 μg/mL and 3.9 μg/mL, respectively) as compared with the reference drug fluconazole (15.62 μg/mL). Their anti-Candida activity is also supported by molecular docking studies, using the fungal lanosterol C14α-demethylase as the target enzyme. The interaction of the most biologically active synthesized compound 7e with bovine serum albumin was investigated through fluorescence spectroscopy, and the obtained data suggested that this molecule might efficiently bind carrier proteins in vivo in order to reach the target site.
Collapse
Affiliation(s)
- Andreea-Iulia Pricopie
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
| | - Ioana Ionuț
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
| | - Gabriel Marc
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
| | - Anca-Maria Arseniu
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
- Preclinic Department, Pharmacy Specialization, Faculty of Medicine, Lucian Blaga University of Sibiu, 2A Lucian Blaga Street, 550169 Sibiu, Romania.
| | - Laurian Vlase
- Department of Pharmaceutical Technology and Biopharmaceutics, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
| | - Adriana Grozav
- Department of Organic Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
| | - Luiza Ioana Găină
- Research Center on Fundamental and Applied Heterochemistry, Faculty of Chemistry and Chemical Engineering, "Babeş-Bolyai" University, 11 Arany Janos Street, 400028 Cluj-Napoca, Romania.
| | - Dan C Vodnar
- Department of Food Science and Technology, University of Agricultural Sciences and Veterinary Medicine, 3-5 Mănăștur Street, 400372 Cluj-Napoca, Romania.
| | - Adrian Pîrnău
- National Institute for Research and Development of Isotopic and Molecular Technologies, 67-103 Donath Street, 400293 Cluj-Napoca, Romania.
| | - Brîndușa Tiperciuc
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
| | - Ovidiu Oniga
- Department of Pharmaceutical Chemistry, "Iuliu Hațieganu" University of Medicine and Pharmacy, 41 Victor Babeș Street, 400012 Cluj-Napoca, Romania.
| |
Collapse
|
4
|
Searching for new agents active against Candida albicans biofilm: A series of indole derivatives, design, synthesis and biological evaluation. Eur J Med Chem 2019; 165:93-106. [DOI: 10.1016/j.ejmech.2019.01.012] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/26/2018] [Revised: 09/14/2018] [Accepted: 01/06/2019] [Indexed: 11/19/2022]
|
5
|
Karaca Gençer H, Acar Çevik U, Kaya Çavuşoğlu B, Sağlık BN, Levent S, Atlı Ö, Ilgın S, Özkay Y, Kaplancıklı ZA. Design, synthesis, and evaluation of novel 2-phenylpropionic acid derivatives as dual COX inhibitory-antibacterial agents. J Enzyme Inhib Med Chem 2019; 32:732-745. [PMID: 28413890 PMCID: PMC6445163 DOI: 10.1080/14756366.2017.1310726] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023] Open
Affiliation(s)
- Hülya Karaca Gençer
- a Department of Pharmaceutical Microbiology, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Ulviye Acar Çevik
- b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.,c Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Betül Kaya Çavuşoğlu
- b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Begüm Nurpelin Sağlık
- b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.,c Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Serkan Levent
- b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.,c Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Özlem Atlı
- d Department of Pharmaceutical Toxicology, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Sinem Ilgın
- d Department of Pharmaceutical Toxicology, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Yusuf Özkay
- b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey.,c Doping and Narcotic Compounds Analysis Laboratory, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| | - Zafer Asım Kaplancıklı
- b Department of Pharmaceutical Chemistry, Faculty of Pharmacy , Anadolu University , Eskişehir , Turkey
| |
Collapse
|
6
|
Zhao S, Huang J, Sun X, Huang X, Fu S, Yang L, Liu X, He F, Deng Y. (1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives suppress Candida albicans virulence by interfering with morphological transition. Microb Biotechnol 2018; 11:1080-1089. [PMID: 30221456 PMCID: PMC6196381 DOI: 10.1111/1751-7915.13307] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2018] [Revised: 07/14/2018] [Accepted: 07/31/2018] [Indexed: 11/30/2022] Open
Abstract
Clinical treatment of Candida albicans infections has become more difficult due to the limited development of antifungal agents and the rapid emergence of drug resistance. In this study, we demonstrate the synthesis of a series of piperazine derivatives and the evaluation of their inhibitory activity against C. albicans virulence. Thirty-four (1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives, including 25 new compounds, were synthesized and assessed for their efficacy against the physiology and pathogenesis of C. albicans. Several compounds strongly inhibited the morphological transition and virulence of C. albicans cells, although they did not influence the growth rate of the fungal pathogen. A leading novel compound, (1-(4-ethoxyphenyl)-4-(1-biphenylol-2-hydroxypropyl)-piperazine), significantly attenuated C. albicans virulence by interfering with the process of hyphal development, but it showed no cytotoxicity against human cells at a micromolar level. These findings suggest that (1-aryloxy-2-hydroxypropyl)-phenylpiperazine derivatives could potentially be developed as novel therapeutic agents for the clinical treatment of C. albicans infections by interfering with morphological transition and virulence.
Collapse
Affiliation(s)
- Shuo Zhao
- State Key Laboratory for Conservation and Utilization of Subtropical Agro‐BioresourcesSouth China Agricultural UniversityGuangzhou510642China
- Guangdong Innovative Research Team of SociomicrobiologyCollege of AgricultureSouth China Agricultural UniversityGuangzhou510642China
- Integrative Microbiology Research CentreSouth China Agricultural UniversityGuangzhou510642China
| | - Jun‐Jun Huang
- Pharmaceutical Research CenterSchool of PharmacologyGuangzhou Medical UniversityGuangzhou510182China
| | - Xiuyun Sun
- State Key Laboratory for Conservation and Utilization of Subtropical Agro‐BioresourcesSouth China Agricultural UniversityGuangzhou510642China
- Guangdong Innovative Research Team of SociomicrobiologyCollege of AgricultureSouth China Agricultural UniversityGuangzhou510642China
- Integrative Microbiology Research CentreSouth China Agricultural UniversityGuangzhou510642China
| | - Xiaorong Huang
- Guangdong Innovative Research Team of SociomicrobiologyCollege of AgricultureSouth China Agricultural UniversityGuangzhou510642China
| | - Shuna Fu
- State Key Laboratory for Conservation and Utilization of Subtropical Agro‐BioresourcesSouth China Agricultural UniversityGuangzhou510642China
- Guangdong Innovative Research Team of SociomicrobiologyCollege of AgricultureSouth China Agricultural UniversityGuangzhou510642China
- Integrative Microbiology Research CentreSouth China Agricultural UniversityGuangzhou510642China
| | - Liang Yang
- Singapore Centre for Environmental Life Sciences Engineering (SCELSE)Nanyang Technological UniversitySingapore637551Singapore
| | - Xue‐Wei Liu
- Division of Chemistry and Biological ChemistrySchool of Physical and Mathematical SciencesNanyang Technological University21 Nanyang LinkSingapore637371Singapore
| | - Fei He
- Integrative Microbiology Research CentreSouth China Agricultural UniversityGuangzhou510642China
| | - Yinyue Deng
- State Key Laboratory for Conservation and Utilization of Subtropical Agro‐BioresourcesSouth China Agricultural UniversityGuangzhou510642China
- Guangdong Innovative Research Team of SociomicrobiologyCollege of AgricultureSouth China Agricultural UniversityGuangzhou510642China
- Integrative Microbiology Research CentreSouth China Agricultural UniversityGuangzhou510642China
| |
Collapse
|
7
|
Savanur HM, Pawashe GM, Kim KM, Kalkhambkar RG. Synthesis and Molecular Modeling Studies of Coumarin- and 1-Aza-Coumarin-Linked Miconazole Analogues and Their Antifungal Activity. ChemistrySelect 2018. [DOI: 10.1002/slct.201801408] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Affiliation(s)
- Hemantkumar M. Savanur
- Department of Chemistry; Karnatak University's Karnatak Science College; Dharwad Karnatak 580001 India
| | - Geeta M. Pawashe
- Department of Chemistry; Karnatak University's Karnatak Science College; Dharwad Karnatak 580001 India
| | - Kang Min Kim
- Department of Pharmaceutical science and technology; Kyungsung, University; Busan 608-736 Korea
| | - Rajesh G. Kalkhambkar
- Department of Chemistry; Karnatak University's Karnatak Science College; Dharwad Karnatak 580001 India
| |
Collapse
|
8
|
Synthesis, anticonvulsant activity, and molecular modeling studies of novel 1-phenyl/1-(4-chlorophenyl)-2-(1H-triazol-1-yl)ethanol ester derivatives. Med Chem Res 2018. [DOI: 10.1007/s00044-018-2225-6] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
9
|
Synthesis and Anticandidal Activity of New Imidazole-Chalcones. Molecules 2018; 23:molecules23040831. [PMID: 29617329 PMCID: PMC6017838 DOI: 10.3390/molecules23040831] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/23/2018] [Revised: 03/28/2018] [Accepted: 03/29/2018] [Indexed: 11/16/2022] Open
Abstract
In the present work, 15 new 1-(4-(1H-imidazol-1-yl)phenyl)-3-(4-substituedphenyl)prop-2-en-1-one derivatives (3a–3o) were synthesized to evaluate their antifungal activity. Structures of newly synthesized imidazole derivatives (3a–3o) were characterized by IR, 1H-NMR, 13C-NMR, and LCMSMS spectroscopic methods. The anticandidal activity of compounds (3a–3o) against C. albicans (ATCC 24433), C. krusei (ATCC 6258), C. parapsilosis (ATCC 22019), and C. glabrata (ATCC 90030) was elucidated according to the EUCAST definitive (EDef 7.1) method. Consistent with the activity studies, 3a–3d were found to be more potent derivatives with their MIC50 values (0.78 µg/mL–3.125 µg/mL) against Candida strains. Compound 3c indicated similar antifungal activity to ketoconazole against all Candida species and was evaluated as the most active derivative in the series. Effects of the most potent derivatives 3a–3d on ergosterol biosynthesis were observed by LC-MS-MS method, which is based on quantification of the ergosterol level in C. krusei. Moreover, these compounds were subjected to a cytotoxicity test for the preliminary toxicological profiles and were found as non-cytotoxic. Furthermore, docking studies for the most active derivative 3c were performed to evaluate its binding modes on lanosterol 14-α-demethylase. In addition to in vitro tests, docking studies also revealed that Compound 3c is a potential ergosterol biosynthesis inhibitor.
Collapse
|
10
|
Doğan İS, Saraç S, Sari S, Kart D, Eşsiz Gökhan Ş, Vural İ, Dalkara S. New azole derivatives showing antimicrobial effects and their mechanism of antifungal activity by molecular modeling studies. Eur J Med Chem 2017; 130:124-138. [DOI: 10.1016/j.ejmech.2017.02.035] [Citation(s) in RCA: 39] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/08/2016] [Revised: 01/20/2017] [Accepted: 02/13/2017] [Indexed: 11/30/2022]
|
11
|
Santos TF, de Jesus JB, Neufeld PM, Jordão AK, Campos VR, Cunha AC, Castro HC, de Souza MCBV, Ferreira VF, Rodrigues CR, Abreu PA. Exploring 1,2,3-triazole derivatives by using in vitro and in silico assays to target new antifungal agents and treat Candidiasis. Med Chem Res 2017. [DOI: 10.1007/s00044-017-1789-x] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
12
|
De Vita D, Simonetti G, Pandolfi F, Costi R, Di Santo R, D'Auria FD, Scipione L. Exploring the anti-biofilm activity of cinnamic acid derivatives in Candida albicans. Bioorg Med Chem Lett 2016; 26:5931-5935. [PMID: 27838185 DOI: 10.1016/j.bmcl.2016.10.091] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2016] [Revised: 10/29/2016] [Accepted: 10/31/2016] [Indexed: 12/11/2022]
Abstract
Some compounds, characterized by phenylethenyl moiety, such as methyl cinnamate and caffeic acid phenethyl ester, are able to inhibit C. albicans biofilm formation. On these bases, and as a consequence of our previous work, we synthesized a series of cinnamoyl ester and amide derivatives in order to evaluate them for the activity against C. albicans biofilm and planktonically grown cells. The most active compounds 7 and 8 showed ⩾50% biofilm inhibition concentrations (BMIC50) of 2μg/mL and 4μg/mL respectively, against C. albicans biofilm formation; otherwise, 7 showed an interesting activity also against mature biofilm, with BMIC50 of 8μg/mL.
Collapse
Affiliation(s)
- Daniela De Vita
- Department of Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy
| | - Giovanna Simonetti
- Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy
| | - Fabiana Pandolfi
- Department of Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy
| | - Roberta Costi
- Department of Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy; "Istituto Pasteur-Fondazione Cenci Bolognetti", Department of Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy
| | - Roberto Di Santo
- Department of Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy; "Istituto Pasteur-Fondazione Cenci Bolognetti", Department of Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy
| | - Felicia Diodata D'Auria
- Department of Public Health and Infectious Diseases, "Sapienza" University of Rome, Piazzale Aldo Moro 5, 00185 Rome, Italy
| | - Luigi Scipione
- "Istituto Pasteur-Fondazione Cenci Bolognetti", Department of Chimica e Tecnologie del Farmaco, Sapienza University of Rome, P.le A. Moro, 5, I-00185 Rome, Italy.
| |
Collapse
|
13
|
De Vita D, Moraca F, Zamperini C, Pandolfi F, Di Santo R, Matheeussen A, Maes L, Tortorella S, Scipione L. In vitro screening of 2-(1H-imidazol-1-yl)-1-phenylethanol derivatives as antiprotozoal agents and docking studies on Trypanosoma cruzi CYP51. Eur J Med Chem 2016; 113:28-33. [DOI: 10.1016/j.ejmech.2016.02.028] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2015] [Revised: 01/18/2016] [Accepted: 02/10/2016] [Indexed: 01/12/2023]
|
14
|
Ramírez-Villalva A, González-Calderón D, González-Romero C, Morales-Rodríguez M, Jauregui-Rodríguez B, Cuevas-Yáñez E, Fuentes-Benítes A. A facile synthesis of novel miconazole analogues and the evaluation of their antifungal activity. Eur J Med Chem 2015; 97:275-9. [DOI: 10.1016/j.ejmech.2015.04.047] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2015] [Revised: 04/22/2015] [Accepted: 04/23/2015] [Indexed: 10/23/2022]
|
15
|
Ranjan P, Kitawat BS, Singh M. 1-Butylimidazole-derived ionic liquids: synthesis, characterisation and evaluation of their antibacterial, antifungal and anticancer activities. RSC Adv 2014. [DOI: 10.1039/c4ra08370a] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Abstract
The reaction of 1-butylimidazole (1a) with aryl/alkoxy halides (2a–h) using a microwave solvent-free approach delivered imidazolium-based ILs (3a–h) in good yield. Some of them showed promising antibacterial and antifungal activities.
Collapse
Affiliation(s)
- Prabodh Ranjan
- School of Chemical Sciences
- Central University of Gujarat
- Gandhinagar-382030, India
| | - Bheru Singh Kitawat
- School of Chemical Sciences
- Central University of Gujarat
- Gandhinagar-382030, India
| | - Man Singh
- School of Chemical Sciences
- Central University of Gujarat
- Gandhinagar-382030, India
| |
Collapse
|